TC regimen: Difference between revisions

	WikiDoc Resources for TC regimen
Articles
Most recent articles on TC regimen Most cited articles on TC regimen Review articles on TC regimen Articles on TC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on TC regimen Images of TC regimen Photos of TC regimen Podcasts & MP3s on TC regimen Videos on TC regimen
Evidence Based Medicine
Cochrane Collaboration on TC regimen Bandolier on TC regimen TRIP on TC regimen
Clinical Trials
Ongoing Trials on TC regimen at Clinical Trials.gov Trial results on TC regimen Clinical Trials on TC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on TC regimen NICE Guidance on TC regimen NHS PRODIGY Guidance FDA on TC regimen CDC on TC regimen
Books
Books on TC regimen
News
TC regimen in the news Be alerted to news on TC regimen News trends on TC regimen
Commentary
Blogs on TC regimen
Definitions
Definitions of TC regimen
Patient Resources / Community
Patient resources on TC regimen Discussion groups on TC regimen Patient Handouts on TC regimen Directions to Hospitals Treating TC regimen Risk calculators and risk factors for TC regimen
Healthcare Provider Resources
Symptoms of TC regimen Causes & Risk Factors for TC regimen Diagnostic studies for TC regimen Treatment of TC regimen
Continuing Medical Education (CME)
CME Programs on TC regimen
International
TC regimen en Espanol TC regimen en Francais
Business
TC regimen in the Marketplace Patents on TC regimen
Experimental / Informatics
List of terms related to TC regimen

Latest revision as of 16:11, 31 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Taxotere-Cyclophosphamide regimen

TC regimen refers to a regimen consisting of docetaxel and cyclophosphamide used to treat breast cancer.^[1]

TDocetaxel (Taxotere)

CCyclophosphamide (Cytoxan)

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{AV}}
-{{SK}}
+{{SK}} Taxotere-Cyclophosphamide regimen
 ==Overview==
-{{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx.
+{{PAGENAME}} refers to a regimen consisting of [[docetaxel]] and [[cyclophosphamide]] used to treat [[breast cancer]].<ref name="pmid17135639">{{cite journal| author=Jones SE, Savin MA, Holmes FA, O'Shaughnessy JA, Blum JL, Vukelja S et al.| title=Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. | journal=J Clin Oncol | year= 2006 | volume= 24 | issue= 34 | pages= 5381-7 | pmid=17135639 | doi=10.1200/JCO.2006.06.5391 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17135639  }} </ref>
 ==Regimen==
@@ Line 14: / Line 14: @@
 ==Indications==
+* [[Breast cancer]]<ref name="pmid17135639">{{cite journal| author=Jones SE, Savin MA, Holmes FA, O'Shaughnessy JA, Blum JL, Vukelja S et al.| title=Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. | journal=J Clin Oncol | year= 2006 | volume= 24 | issue= 34 | pages= 5381-7 | pmid=17135639 | doi=10.1200/JCO.2006.06.5391 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17135639  }} </ref>
 ==References==